CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Class A
Common Stock
Class A
Common Stock
Class C
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Total Shareholders’ Equity
Non-controlling Interest
Common shares outstanding at beginning of period (in shares) at Dec. 31, 2019     280,650,000 1,034,000        
Balance at beginning of period at Dec. 31, 2019 $ 3,270,701   $ 28 $ 0 $ 2,975,756 $ 282,336 $ 3,258,120 $ 12,581
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock issued (in shares)     1,305,000          
Restricted stock forfeited (in shares)     (406,000)          
Restricted stock used for tax withholding (in shares)     (78,000)          
Restricted stock used for tax withholding (208)       (208)   (208)  
Issuance of Class A common stock under Employee Stock Purchase Plan (in shares)     59,000          
Issuance of Class A common stock under Employee Stock Purchase Plan 230       230   230  
Stock-based compensation - equity awards 6,409       6,409   6,409  
Net income (loss) (550,345)         (547,983) (547,983) (2,362)
Common shares outstanding at end of period (in shares) at Mar. 31, 2020     281,530,000 1,034,000        
Balance at end of period at Mar. 31, 2020 2,726,787   $ 28 $ 0 2,982,187 (265,647) 2,716,568 10,219
Common shares outstanding at beginning of period (in shares) at Dec. 31, 2020   278,551,901 290,646,000 0        
Balance at beginning of period at Dec. 31, 2020 2,603,961   $ 29 $ 0 3,004,433 (400,501) 2,603,961 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock forfeited (in shares)     (1,000)          
Restricted stock used for tax withholding (in shares)     (128,000)          
Restricted stock used for tax withholding (477)       (477)   (477)  
Issuance of Class A common stock under Employee Stock Purchase Plan (in shares)     276,000          
Issuance of Class A common stock under Employee Stock Purchase Plan 167       167   167  
Stock-based compensation - equity awards 4,585       4,585   4,585  
Capped call premiums (14,688)       (14,688)   (14,688)  
Net income (loss) (34,645)         (34,645) (34,645)  
Common shares outstanding at end of period (in shares) at Mar. 31, 2021   279,124,752 290,793,000 0        
Balance at end of period at Mar. 31, 2021 $ 2,558,903   $ 29 $ 0 $ 2,994,020 $ (435,146) $ 2,558,903 $ 0